Abstract
Occurrence of drug resistance is one of the most relevant limitations in lung cancer therapy. At the beginning of the targeted therapy era, oncologists believed that new targeted agents might lead to a definitve cure in patients with advanced lung cancer. Unfortunately, even if targeted therapies are extending survival, all patients inevitably relapse after an initial response, and some patients are resistant even in the presence of the drug target. Identification of mechanisms responsible for drug resistance is important because of the potential consequences to patient therapy, quality of life and survival.
Chapter PDF
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Cappuzzo, F. (2015). Conclusion. In: Guide to Targeted Therapies: Treatment Resistance in Lung Cancer. Adis, Cham. https://doi.org/10.1007/978-3-319-20741-4_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-20741-4_7
Published:
Publisher Name: Adis, Cham
Print ISBN: 978-3-319-20740-7
Online ISBN: 978-3-319-20741-4
eBook Packages: MedicineMedicine (R0)